275 related articles for article (PubMed ID: 17912043)
1. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
Tallett AJ; Blundell JE; Rodgers JR
Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
[TBL] [Abstract][Full Text] [Related]
2. Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Psychopharmacology (Berl); 2007 Nov; 195(1):27-39. PubMed ID: 17639351
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2009 Jan; 91(3):358-66. PubMed ID: 18755211
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.
Hodge J; Bow JP; Plyler KS; Vemuri VK; Wisniecki A; Salamone JD; Makriyannis A; McLaughlin PJ
Behav Brain Res; 2008 Nov; 193(2):298-305. PubMed ID: 18602425
[TBL] [Abstract][Full Text] [Related]
5. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
[TBL] [Abstract][Full Text] [Related]
6. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.
McLaughlin PJ; Winston KM; Limebeer CL; Parker LA; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 2005 Jul; 180(2):286-93. PubMed ID: 15948012
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
Physiol Behav; 2004 Mar; 81(1):129-40. PubMed ID: 15059692
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
Tallett AJ; Blundell JE; Rodgers RJ
Physiol Behav; 2008 Jun; 94(3):422-31. PubMed ID: 18394662
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):92-100. PubMed ID: 20026165
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates.
Foltin RW; Haney M
Pharmacol Biochem Behav; 2007 Apr; 86(4):766-73. PubMed ID: 17445873
[TBL] [Abstract][Full Text] [Related]
12. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Jeffrey P; Summerfield S; Rodgers RJ
Behav Brain Res; 2005 Feb; 157(2):331-41. PubMed ID: 15639184
[TBL] [Abstract][Full Text] [Related]
13. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
Rutkowska M
Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698
[TBL] [Abstract][Full Text] [Related]
14. Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
Wright FL; Rodgers RJ
Psychopharmacology (Berl); 2013 Mar; 226(2):415-31. PubMed ID: 23142959
[TBL] [Abstract][Full Text] [Related]
15. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
[TBL] [Abstract][Full Text] [Related]
16. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA
Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185
[TBL] [Abstract][Full Text] [Related]
19. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
[TBL] [Abstract][Full Text] [Related]
20. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.
Gardner A; Mallet PE
Eur J Pharmacol; 2006 Jan; 530(1-2):103-6. PubMed ID: 16380113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
